Zimmer Biomet Holdings, Inc. has announced a definitive agreement to acquire Monogram Technologies Inc., an orthopedic robotics company, for an upfront payment of $4.04 per share in cash, valuing the equity at approximately $177 million. The acquisition, which has been unanimously approved by the boards of both companies, aims to expand Zimmer Biomet's portfolio with Monogram's autonomous surgical solutions. The deal is expected to be neutral to adjusted earnings per share between 2025 and 2027 and contribute to revenue growth starting in 2027. Monogram stockholders will also receive a contingent value right, potentially offering up to $12.37 per share if certain milestones are met by 2030.